Effects of Liraglutide on Myocardial Function After Cardiac Surgery: A Secondary Analysis of the Randomised Controlled GLOBE Trial.
Abraham H HulstMaarten J VisscherThomas G V CherpanathLieke van de WouwMarc B GodfriedBram ThielBastiaan M GerritseThierry V ScohyR Arthur BouwmanMark G A WillemsenMarkus W HollmannJ Hans DeVriesBenedikt PreckelJeroen HermanidesPublished in: Journal of clinical medicine (2020)
Patients receiving short-term preoperative liraglutide treatment better maintained normal myocardial function after cardiac surgery. This study warrants further evaluation of the potential beneficial effects of GLP-1 receptor agonists in cardiac surgery patients.
Keyphrases
- cardiac surgery
- end stage renal disease
- study protocol
- left ventricular
- newly diagnosed
- ejection fraction
- chronic kidney disease
- acute kidney injury
- clinical trial
- prognostic factors
- patients undergoing
- heart failure
- patient reported outcomes
- risk assessment
- phase iii
- climate change
- combination therapy
- patient reported